Polsinelli Podcasts - FDA Denies Amgen Citizen Petition in Biosimilar Dispute
After granting the plaintiffs’ Rule 23(f) petition, the Ninth Circuit reversed a denial of class certification, finding that the district court had improperly weighed the merits of the plaintiffs’ Rule 23(a)(2) commonality...more